Traws Pharma, Inc. — Director's Dealing 2019

Nov 27, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2019-11-25

Reporting Person: MEHTA VIREN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-25	Common Stock	P	250000	$.2	Acquired	250857	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-25	Warrant (right to purchase)	$.2	P	250000	Acquired	2024-11-25	Common Stock (250000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	54	Indirect
Common Stock	56	Indirect

Footnotes

F1: The common stock and warrants were acquired in a public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. The public offering price for each unit was $0.20.

F2: Includes 190 shares held jointly with Dr. Mehta's spouse.

F3: Dr. Mehta, as managing member, has voting and dispositive power with regard to the shares held by Mehta Partners, LLC.

F4: Dr. Mehta, as trustee, has voting and dispositive power with regard to the shares held by Viram Foundation.